Largest health care biotech companies by total assets

Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.

Amgen leads the 24 health care biotech companies ranked by total assets, at NZ$164.8B, ahead of Gilead Sciences (NZ$107.4B) and Biogen (NZ$53.6B). Figures as of 20 Nov 2026, 04:27 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenNZ$164.8B
Median
NZ$4.6B
Combined market value
NZ$1.51T
Countries
5

Market values as of .

All countries
Health Care
Biotech
NZD
Clear filters
Largest health care biotech companies by total assets
#CompanyTotal assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareNZ$164.8BNZ$431.8BNZ$798.21 1.14% down 32% up United States
2Gilead SciencesGILD · Health CareNZ$107.4BNZ$375.7BNZ$302.92 1.45% down 35% up United States
3BiogenBIIB · Health CareNZ$53.6BNZ$66.4BNZ$449.53 1.70% down 49% up United States
4BioNTechBNTX · Health CareNZ$44.4BNZ$36.7BNZ$148.03 2.26% down 14% down Germany
5ModernaMRNA · Health CareNZ$22.4BNZ$146.7BNZ$362.58 1.29% up 780% up United States
6argenxARGX · Health CareNZ$15.8BNZ$107.8BNZ$1,713.57 0.08% up 2% up Belgium
7QiagenQGEN · Health CareNZ$11.4BNZ$18.6BNZ$90.28 0.14% up 9% up Netherlands
8Neurocrine BiosciencesNBIX · Health CareNZ$8.4BNZ$28.8BNZ$284.84 3.85% down 17% up United States
9VaxcytePCVX · Health CareNZ$5.5BNZ$16.8BNZ$106.16 0.27% down 23% up United States
10RepligenRGEN · Health CareNZ$5.4BNZ$19.8BNZ$309.76 1.38% down 12% up United States
11ExelixisEXEL · Health CareNZ$5.2BNZ$29.2BNZ$119.74 3.60% down 63% up United States
12Bio-TechneTECH · Health CareNZ$4.7BNZ$20.8BNZ$132.24 0.07% down 24% up United States
13Halozyme TherapeuticsHALO · Health CareNZ$4.6BNZ$19.3BNZ$169.24 2.88% down 39% up United States
14Revolution MedicinesRVMD · Health CareNZ$4.3BNZ$62.7BNZ$290.00 0.24% down 129% up United States
15CRISPR TherapeuticsCRSP · Health CareNZ$4.1BNZ$6.9BNZ$70.81 3.14% down 18% down Switzerland
16Kymera TherapeuticsKYMR · Health CareNZ$3.2BNZ$18.5BNZ$217.17 1.44% down 87% up United States
17Krystal BiotechKRYS · Health CareNZ$2.4BNZ$17BNZ$574.48 0.15% up 54% up United States
18ImmunovantIMVT · Health CareNZ$1.7BNZ$12.2BNZ$59.15 1.96% down 46% up United States
19CG OncologyCGON · Health CareNZ$1.4BNZ$13.3BNZ$148.98 2.38% up 97% up United States
20Twist BioscienceTWST · Health CareNZ$1.2BNZ$13.8BNZ$203.04 4.07% down 346% up United States
21Adaptive BiotechnologiesADPT · Health CareNZ$932.7MNZ$8.3BNZ$51.02 1.44% down 74% up United States
22ImmunityBioIBRX · Health CareNZ$913MNZ$12.7BNZ$11.95 1.94% down 232% up United States
23Scholar Rock HoldingSRRK · Health CareNZ$735.4MNZ$11.2BNZ$91.62 4.94% up 26% up United States
24Kodiak SciencesKOD · Health CareNZ$639.4MNZ$11.6BNZ$178.08 0.09% up 399% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.8190 NZD).

Questions and answers

Which health care biotech companies rank first by total assets?

Amgen (NZ$164.8B), Gilead Sciences (NZ$107.4B) and Biogen (NZ$53.6B) are the top three of the 24 health care biotech companies ranked by total assets as of 20 Nov 2026, 04:27 UTC.

How many health care biotech companies are in this ranking?

24 are ranked by total assets.

What are these health care biotech companies worth together?

The 24 health care biotech companies ranked by total assets have a combined market value of NZ$1.51T as of 20 Nov 2026, 04:27 UTC.

What does ranking by total assets measure?

Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest health care biotech companies by total assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=total-assets

Underlying data: Yahoo Finance; SEC EDGAR.